Search Results 2071-2080 of 18794 for Relapse

  1. Guillain-Barre Syndrome Archives - Mayo Clinic News Network

    ... relapse, Rich was hospitalized again and received intravenous immunoglobin therapy, or IVig, and steroids. He also began physical and occupational therapy ...

  2. Clinical trials - Oncology (Medical)

    ... relapsed NSCLC. Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn ...

  3. Clinical trials - Oncology (Medical)

    ... relapsed NSCLC. Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn ...

  4. Tapering off opioids: When and how - Mayo Clinic

    Counseling can help you learn ways to cope with stress, identify early warning signs of relapse and keep you from taking opioids. Your healthcare ...

  5. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Each unique regimen or 'line' is defined as a single or combination of medications given for a new relapse/recurrence. Maintenance therapies, where ...

  6. An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... relapse or who complete the Maintenance Study RPC01-3203, and subjects who complete a study of ozanimod for Crohn's Disease and meet the criteria for ...

  7. Hematology - Clinical trials

    Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...

  8. Daclizumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used ...

  9. Neurology - Clinical trials

    Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

  10. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

    ... relapsed/refractory multiple myeloma (RRMM). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...